Shanghai Cohort Study of Diabetic Eye Disease
SCODE
A Three-year Community-based Study in Diabetes: The Shanghai Cohort Study of Diabetic Eye Disease
1 other identifier
observational
8,000
0 countries
N/A
Brief Summary
To describe the design, methodology and baseline characteristics of the Shanghai Cohort study of Diabetic Eye disease (SCODE) study, a community-based study to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 30, 2018
CompletedFirst Posted
Study publicly available on registry
September 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedSeptember 11, 2018
September 1, 2018
3 years
August 30, 2018
September 6, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence and incidence rate of diabetic eye disease
SCODE was performed to evaluate the prevalence and rate of new cases of diabetic eye disease, especially DR, in a three-year community-based cohort study for the people with diabetes, and to identify the associated factors related with diabetic eye disease.
December 31, 2018
Secondary Outcomes (6)
Grading of DR
December 31, 2018
Retinal and choroidal thickness
December 31, 2018
Retinal blood flow
December 31, 2018
Blood biochemistry indexes
December 31, 2018
Urine biochemistry indexes
December 31, 2018
- +1 more secondary outcomes
Interventions
Community-based, prospective cohort study from three consecutive years (2016 to 2018) to determine the prevalence and impact of diabetic eye disease, especially diabetic retinopathy (DR), in adults with diabetes living in Shanghai.
Eligibility Criteria
All the enrolled participants got a yearly examination of diabetic eye disease for three years. Considering that the prevalence of DR gradually increases with age, the target population included adults with diabetes aged 35 years and above under archives management, residing in Shanghai. And the study participants were expected to be freely mobile, clear-thinking, and capable of cooperating to complete the ophthalmic examinations.
You may qualify if:
- Adults with diabetes aged 35 years and above; under archives management; residing in Shanghai.
You may not qualify if:
- All the study participants have difficulties of mobility or communication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Xiang Z, Lin S, Xu Y, Lu L, Shi Y, Wang Y, Yang Q, Ling S, Zhou D, Qin X, Cheng M, Zou H, Ma Y. The effects of physical activity on diabetic retinopathy in type 2 diabetes using automated vascular analysis: a cohort study. J Glob Health. 2025 Dec 5;15:04319. doi: 10.7189/jogh.15.04319.
PMID: 41343177DERIVED
Biospecimen
Urine and Blood Sample Collection
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 30, 2018
First Posted
September 11, 2018
Study Start
January 1, 2016
Primary Completion
December 31, 2018
Study Completion
December 31, 2020
Last Updated
September 11, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will be available with in one year of study completion.
- Access Criteria
- Data access requests will be reviewed by an external Independent Review Panel. Requestors will be required to sign a Data Access Agreement.
Identified individual participant data for all primary and secondary outcome measures will be made available.